SXTP — 60 Degrees Pharmaceuticals Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareMicro Cap

Annual cashflow statement for 60 Degrees Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS/A	PROSPECTUS	PROSPECTUS	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-3.05	-4.26	-6.18	-3.81	-7.96
Depreciation
Amortisation
Non-Cash Items	0.426	0.684	1.83	-1.18	2.06
Unusual Items
Other Non-Cash Items
Changes in Working Capital	2.43	2.9	3.31	0.405	0.193
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities	-0.167	-0.649	-1.01	-4.54	-5.65
Capital Expenditures	-0.071	-0.035	-0.06	-0.116	-0.181
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	—	—	—	—	-1.71
Purchase of Investments
Cash from Investing Activities	-0.071	-0.035	-0.06	-0.116	-1.89
Financing Cash Flow Items	—	0	0.117	-0.15	3.41
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	0.277	0.611	1.22	6.47	7.05
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-0.095	-0.076	0.149	1.88	-0.483